Skip to main content

SCHRODER INVESTMENT MANAGEMENT GROUP

Position in APGE — Apogee Therapeutics, Inc.

CIK 1086619 London, X0

Position in APGE

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$4,066,315
-$4,069,220 QoQ
Shares Held
30,636
-68.3% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#131
of 285 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APGE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SCHRODER INVESTMENT MANAGEMENT GROUP holds $692,439,062 across 60 Biotechnology names. APGE ranks #37 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in APGE

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,066,315 30,636
2026-03-31 $8,135,535 96,656
2025-12-31 $7,925,399 105,000
2025-09-30 $8,575,561 215,846
2025-06-30 $5,178,853 119,246
2025-03-31 $3,623,621 96,992
2024-12-31 $2,648,509 58,466
2024-09-30 $3,434,292 58,466
2024-06-30 $4,440,962 112,858